Načítá se...
Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk
PURPOSE: Women with early-onset (age ≤40) breast cancer are at high risk of carrying deleterious mutations in the BRCA1/2 genes; genetic assessment is thus recommended. Knowledge of BRCA1/2 mutation status is useful in guiding treatment decisions. To date, there has been no national study of BRCA1/2...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3604880/ https://ncbi.nlm.nih.gov/pubmed/21358336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GIM.0b013e3182091ba4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|